MHRA Drug Safety Update October 2021
Links to the MHRA Drug Safety Update for October 2021 are listed below.
- Tofacitinib (Xeljanz▼): new measures to minimise risk of major adverse cardiovascular events and malignancies
- Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication
- MedSafetyWeek November 2021: support the safety of vaccines
- COVID-19 vaccines: updates for October 2021
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published 01/11/2021. Medicines Update blogs are correct at the time of publication.